Back to ABUS
Abel Hall, LLC ABUS Position History
Arbutus Biopharma Corporation
Quarters held
4
Latest value
$89K
Q3 2026
Peak value
$148K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $148K |
| Q1 2026 | $90K |
| Q2 2026 | $88K |
| Q3 2026 | $89K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $89K | 18.5K | — | — |
| Q2 2026 | $88K | 18.3K | — | — |
| Q1 2026 | $90K | 20.1K | — | — |
| Q4 2025 | $148K | 30.8K | — | — |
Other funds holding ABUS
$119.1M
$119.1M
$109.8M
$103.4M
$103.4M
$91.7M
$83.5M